Clinical trials Below are current clinical trials.5 studies in Bariatric Center in Florida (open studies only). Filter this list of studies by location, status and more. The Development and Testing of a Shared Decision Making Encounter Tool for Weight Management Decisions Rochester, Minn., Jacksonville, Fla. The aim of this study is to develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding the treatment of obesity (Obesity Choice). A Study to Evaluate the Effectiveness of a Healthy Living Weight Loss Program in Obese Patients Undergoing Bariatric Endoscopy on Weight Loss Outcomes Rochester, Minn. The purpose of this study is to compare weight loss, improvement of comorbidities, improvement of lipid profile, blood sugar in patients undergoing endoscopic sleeve gastroplasty or intragastric balloon between patients who are in a weight loss program and those who are not. ESG Use for Weight Loss in Obese UC Patients Undergoing Colectomy With IPAA Rochester, Minn. The purpose of this study is to evaluate the effectiveness and safety of endoscopic sleeve gastroplasty (ESG) for weight loss in a population of obese ulcerative colitis (UC) patients undergoing colectomy with eventual ileal pouch anal anastomosis (IPAA). Sugar Hyperabsorption Impact on Post-Bariatric Surgery Weight Loss Outcomes in African American Patients Jacksonville, Fla. The purpose of this study is to investigate glucose and fructose absorption in enteroids from obese African American subjects before and 1-year post-bariatric surgery compared to age and sex-matched enteroids from obese Caucasian and Hispanic subjects (controls). Also, to profile the expression of glucose and fructose transporters and gluconeogenic enzymes in intestinal tissue from obese African American subjects and compare it to obese Caucasian and Hispanic subjects pre- and post-bariatric surgery. Pasireotide s.c. in Patients with Post-Bariatric Hypoglycaemia Rochester, Minn. The purpose of this study is to evaluate the efficacy of pasireotide s.c. on level 2 hypoglycaemic events after a mixed meal tolerance test (MMTT) in patients with Post-Bariatric Hypoglycaemia (PBH) after 12 weeks of treatment. Request an appointment DoctorsResearch Dec. 18, 2021 Share on: FacebookTwitter Bariatric Center in FloridaSectionsRequest an appointmentOverviewBariatric programTests & proceduresConditions treatedDoctorsClinical trialsResearchCosts & insuranceReferrals Research: It's all about patients Show transcript for video Research: It's all about patients [MUSIC PLAYING] Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight. SectionsRequest an appointmentOverviewBariatric programTests & proceduresConditions treatedDoctorsClinical trialsResearchCosts & insuranceReferrals ORG-20523450 Medical Departments & Centers Bariatric Center in Florida